IntriCon Corp. (IIN) Raised to Hold at Zacks Investment Research
According to Zacks, “IntriCon designs, develops, engineers and manufactures microminiaturized medical and electronic products. The Company supplies microminiaturized components, systems and molded plastic parts, primarily to the hearing instrument manufacturing industry, as well as the computer, government, electronics, telecommunications and medical equipment industries. The Company has facilities in the United States, Asia and Europe. “
IntriCon Corp. (NASDAQ:IIN) opened at 6.14 on Wednesday. IntriCon Corp. has a 52 week low of $4.12 and a 52 week high of $8.65. The company has a 50-day moving average price of $5.01 and a 200 day moving average price of $5.35. The company’s market cap is $41.72 million.
IntriCon Corp. (NASDAQ:IIN) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by $0.14. IntriCon Corp. had a positive return on equity of 2.36% and a negative net margin of 0.05%. The firm earned $17 million during the quarter, compared to analyst estimates of $16.71 million. On average, equities research analysts forecast that IntriCon Corp. will post ($0.10) EPS for the current fiscal year.
A number of large investors have recently bought and sold shares of IIN. Renaissance Technologies LLC boosted its position in shares of IntriCon Corp. by 0.9% in the first quarter. Renaissance Technologies LLC now owns 171,500 shares of the company’s stock valued at $1,092,000 after buying an additional 1,500 shares in the last quarter. Heartland Advisors Inc. bought a new position in shares of IntriCon Corp. during the second quarter valued at $2,136,000. AWM Investment Company Inc. bought a new position in shares of IntriCon Corp. during the second quarter valued at $294,000. Bard Associates Inc. bought a new position in shares of IntriCon Corp. during the second quarter valued at $211,000. Finally, Coe Capital Management LLC bought a new position in shares of IntriCon Corp. during the second quarter valued at $240,000. Institutional investors own 23.33% of the company’s stock.
About IntriCon Corp.
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Corp. and related companies with MarketBeat.com's FREE daily email newsletter.